Form 8-K
8-K — Guardian Pharmacy Services, Inc.
Accession: 0001193125-26-277596
Filed: 2026-06-22
Period: 2026-06-22
CIK: 0001802255
SIC: 5912 (RETAIL-DRUG STORES AND PROPRIETARY STORES)
Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — d97841d8k.htm (Primary)
EX-99.1 (d97841dex991.htm)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K
8-K (Primary)
Filename: d97841d8k.htm · Sequence: 1
8-K
false 0001802255 0001802255 2026-06-22 2026-06-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 22, 2026
Guardian Pharmacy Services, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-42284
87-3627139
(State or other jurisdiction
of incorporation or organization)
(Commission
File Number)
(IRS Employer
Identification No.)
300 Galleria Parkway SE
Suite 800
Atlanta, Georgia
30339
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (404) 810-0089
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Class A Common Stock, par value $0.001 per share
GRDN
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 22, 2026, Guardian Pharmacy Services, Inc. (the “Company”) announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since the Company was founded in 2004, will retire from all positions with the Company effective July 1, 2026. Upon his retirement, Mr. Forbes has agreed to continue as an employee of the Company from July 1 through August 31, 2026 to assist with the transition of his duties.
The Company also announced on June 22, 2026, that upon Mr. Forbes’s retirement, and also effective as of July 1, 2026, David Morris will transition from his current role as Executive Vice President and Chief Financial Officer of the Company to the role of Executive Vice President, Chief Operating Officer. In connection with Mr. Morris’s transition to his new role, Will Mudd, who currently serves as Senior Vice President, Finance of the Company, has been appointed Senior Vice President and Chief Financial Officer of the Company, also effective as of July 1, 2026.
Mr. Morris, age 63, has served as Executive Vice President and Chief Financial Officer of the Company since our founding in 2004 and as a member of the Company’s board of directors since 2021. Prior to co-founding the Company, Mr. Morris served as Chief Financial Officer at Central Pharmacy from 1993 to 2001. Mr. Morris previously served as President of the PBM Division at Complete Health from 1991 to 1993 and served as a Certified Public Accountant at Ernst & Young LLP from 1985 to 1991. Mr. Morris received a B.S., Accounting from the University of Alabama.
Mr. Mudd, age 47, has served as Senior Vice President, Finance of the Company since 2012, overseeing all financial accounting and reporting, the Company’s complex revenue cycle management and total rewards (compensation & benefits) for the Company. Prior to joining Guadian, Mr. Mudd spent approximately ten years with the audit services group of a global public accounting firm servicing a broad range of clients, ranging from small, private equity backed private companies to mature public companies. Mr. Mudd earned his B.S. in Management with Accounting Concentration from Presbyterian College.
Upon his promotion to Chief Financial Officer, Mr. Mudd will continue to participate in the Company’s compensation programs upon terms commensurate with other executive officers of the Company. Mr. Mudd will not receive any additional compensation in connection with his promotion.
There are no family relationships, as defined in Item 401(d) of Regulation S-K, between Mr. Morris or Mr. Mudd and any of the Company’s directors or executive officers. There is no arrangement or understanding between Mr. Morris or Mr. Mudd and any other person pursuant to which either Mr. Morris or Mr. Mudd was selected for their executive officer positions. There have been no transactions, and no transactions are currently proposed, in which the Company was or is to be a participant and in which either Mr. Morris or Mr. Mudd, or any member of their respective immediate families, had or will have an interest and is required to be disclosed pursuant to Item 404(a) of Regulation S-K.
During the period from July 1, 2026 through August 31, 2026, in compensation for the transition services that he will provide, Mr. Forbes will be entitled to payment of one-half of his current monthly base salary, along with customary health and welfare benefits offered to similarly situated employees.
Item 7.01
Regulation FD Disclosure.
On June 22, 2026, the Company issued a press release announcing the management changes as described herein. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
The information in this Item 7.01 on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise stated in such filing.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No.
Description
99.1
Press Release dated June 22, 2026.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: June 22, 2026
GUARDIAN PHARMACY SERVICES, INC.
By:
/s/ Douglas Towns
Name:
Douglas Towns
Title:
Senior Vice President, General Counsel & Senior Compliance Officer, and Corporate Secretary
EX-99.1
EX-99.1
Filename: d97841dex991.htm · Sequence: 2
EX-99.1
Exhibit 99.1
Guardian Pharmacy Services, Inc. Announces Leadership Transitions
Executive Vice President Kendall Forbes to Retire on July 1, 2026
Guardian Names David Morris as Chief Operating Officer and Will Mudd as Chief Financial Officer
ATLANTA, GA — Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall Forbes, who has served as Executive Vice President of
Sales & Operations since 2004, has decided to retire, effective as of July 1, 2026. Upon Mr. Forbes’s retirement, David Morris, currently Executive Vice President and Chief Financial Officer of Guardian will assume the role
of Chief Operating Officer. In connection with Mr. Morris’ new role, Will Mudd, Senior Vice President, Finance, has been appointed Chief Financial Officer of Guardian. The leadership changes will be effective July 1, 2026.
Fred Burke, President and Chief Executive Officer of Guardian said: “Kendall Forbes has been an integral part of Guardian since its inception, and his
impact on the company has been significant. Over the past 22 years, Kendall played a key role in building and scaling our sales and operations infrastructure, helping establish the foundation for the Guardian we know today. On behalf of all the team
members at Guardian, I want to thank Kendall for his many contributions across his distinguished career and wish him all the best in his retirement.”
Burke continued: “I am also extremely pleased that David Morris will assume the role of Chief Operating Officer. David has served as our Chief Financial
Officer since Guardian’s founding and has been a trusted member of our Executive Leadership Team throughout the Company’s growth. He brings a deep understanding of our business and our financial discipline, and has built strong,
long-standing relationships with leaders across the organization. These qualities make him exceptionally well suited to lead Guardian’s operating functions through our next phase of growth. This will be a seamless transition, as David will
have the opportunity in his new role to further broaden his current operational involvement across the business.”
Mr. Mudd has served as
Senior Vice President, Finance of the Company since 2012, overseeing financial accounting and reporting, revenue cycle management, and human resources. Prior to joining Guardian, Mr. Mudd spent approximately ten years with the audit services
group at Grant Thornton servicing a broad range of clients, ranging from small, private equity-backed private companies to mature public companies.
Burke
added, “I am thrilled that Will Mudd will succeed David as CFO. Will has been instrumental in helping to build our finance and accounting organization and played a critical role in our transition to a public company. He is well prepared, has
earned this opportunity, and is extremely well positioned to lead our finance team alongside David and me as we continue to grow.”
Together, these
organizational changes underscore the depth of Guardian’s leadership team, the Company’s disciplined approach to succession planning, and its continued commitment to developing and advancing talent from within as the company grows.
About Guardian Pharmacy Services
Guardian Pharmacy Services is one of the nation’s leading long-term care pharmacy services companies. Through its locally-based business model, Guardian
partners with long-term care facilities (“LTCFs”) to deliver medications and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and
improve clinical outcomes. With a growing network of 61 licensed pharmacies, of which 54 are full-service, Guardian is dedicated to providing exceptional service to approximately 207,000 residents (as of March 31, 2026).
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements
are all statements other than those of historical fact. Words such as “aims,” “anticipates,” “believes,” “contemplates,” “continues,” “estimates,” “expects,”
“intends,” “may,” “plans,” “seeks,” “should,” “will,” “would” and similar expressions are often, but not always, used to identify forward-looking statements. These
forward-looking statements are based on management’s current expectations and beliefs and are inherently subject to risks and uncertainties, including, among others, uncertainties related to market conditions, and those other risks and
uncertainties more fully described under “Risk Factors” in Guardian’s Annual Report on Form 10-K for the year ended December 31, 2025. Except to the extent required by applicable law,
Guardian undertakes no obligation to update or revise any information contained in this press release beyond the published date, whether as a result of new information, future events or otherwise.
Investor Contact
Ashley Stockton
Vice President, Investor Relations
IR@guardianpharmacy.net
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 7
v3.26.1
Document and Entity Information
Jun. 22, 2026
Cover [Abstract]
Amendment Flag
false
Entity Central Index Key
0001802255
Document Type
8-K
Document Period End Date
Jun. 22, 2026
Entity Registrant Name
Guardian Pharmacy Services, Inc.
Entity Incorporation State Country Code
DE
Entity File Number
001-42284
Entity Tax Identification Number
87-3627139
Entity Address, Address Line One
300 Galleria Parkway SE
Entity Address, Address Line Two
Suite 800
Entity Address, City or Town
Atlanta
Entity Address, State or Province
GA
Entity Address, Postal Zip Code
30339
City Area Code
(404)
Local Phone Number
810-0089
Written Communications
false
Soliciting Material
false
Pre Commencement Tender Offer
false
Pre Commencement Issuer Tender Offer
false
Security 12b Title
Class A Common Stock, par value $0.001 per share
Trading Symbol
GRDN
Security Exchange Name
NYSE
Entity Emerging Growth Company
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration